Lei Yang

Prof. Lei Yang

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Oncology Research
Verified
Journal Article
Open access
PDF file
XSXinrui Shi
Xinrui Shi
XGXia Gao
Xia Gao
WLWencong Liu
Wencong Liu
XTXuejiao Tang
Xuejiao Tang
JLJiayi Liu
Jiayi Liu
WLWen-Xuan Liu
Wen-Xuan Liu
Hepatocellular carcinoma (HCC) is the most common fatal cancer worldwide, patients with HCC have a high mortality rate and poor prognosis. PANoptosis is a novel discovery of programmed cell death associated with cancer development. However, the role of PANoptosis in HCC remains obscure. In this study, we enrolled 274 PANoptosisrelated genes (PANRGs) and screened 8 genes to set up a prognostic model. A previous scoring system calculated PANscore was utilized to quantify the individual risk level of each HCC patient, and the reliability of the prognostic model has been validated in an external cohort. Nomogram constructed with PANscore and clinical characteristics were used to optimize individualized treatment for each patient. Single-cell analysis revealed a PANoptosis model associated with tumor immune cell infiltration, particularly natural killer (NK) cells. Further exploration of hub genes and assessment of the prognostic role of these 4 hub genes in HCC by quantitative real-time PCR (qRT-PCR) and immunohistochemistry (IHC). In conclusion, we evaluated a PANoptosis-based prognostic model as a potential prognostic biomarker for HCC patients.

1 August 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
FLFang Liu
Fang Liu
JLJiayi Liu
Jiayi Liu
XSXinrui Shi
Xinrui Shi
XHXiaojie Hu
Xiaojie Hu
LWLai Wei
Lai Wei
LYlei yang
lei yang
Inhibin subunit beta A (INHBA) is a member of the transforming growth factor-beta (TGF-β) superfamily that plays a fundamental role in various cancers. However, a systematic analysis of the exact role of INHBA in patients with gastric cancer (GC) has not yet been conducted. We evaluated the expression levels of INHBA and the correlation between INHBA and GC prognosis in GC. The relationship between INHBA expression, immune infiltration levels, and type markers of immune cells in GC was also explored. In addition, we studied INHBA mutations, promoter methylation, and functional enrichment analysis. Besides, high expression levels of INHBA in GC were significantly related to unfavorable prognosis. INHBA was negatively correlated with B cell infiltration, but positively correlated with macrophage and most anticancer immunity steps. INHBA expression was positively correlated with the type markers of CD8+ T cells, neutrophils, macrophages, and dendritic cells. INHBA has a weak significant methylation level change between tumor and normal tissues and mainly enriched in cancer-related signaling pathways. The present study implies that INHBA may serve as a potential biomarker for predicting the prognosis of patients with GC. INHBA is a promising predictor of immunotherapy response, with higher levels of INHBA indicating greater sensitivity.

5 May 2020 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
HLHong‐Min Luo
Hong‐Min Luo
XWXia Wu
Xia Wu
XXXian Xian
Xian Xian
LWLu‐Yao Wang
Lu‐Yao Wang
LZLiang‐Yu Zhu
Liang‐Yu Zhu
WLWen-Xuan Liu
Wen-Xuan Liu
We had previously demonstrated that the calcitonin gene‐related peptide (CGRP) suppresses the oxidative stress and vascular smooth muscle cell (VSMC) proliferation induced by vascular injury. A recent study also indicated that CGRP protects against the onset and development of angiotensin II (Ang II)‐induced hypertension, vascular hypertrophy and oxidative stress. However, the mechanism behind the effects of CGRP on Ang II‐induced oxidative stress is unclear. CGRP significantly suppressed the level of reactive oxygen species (ROS) generated by NADPH oxidase in Ang II‐induced VSMCs. The Ang II‐stimulated activation of both Src and the downstream transcription factor, STAT3, was abrogated by CGRP. However, the antioxidative effect of CGRP was lost following the expression of constitutively activated Src or STAT3. Pre‐treatment with H‐89 or CGRP8–37 also blocked the CGRP inhibitory effects against Ang II‐induced oxidative stress. Additionally, both in vitro and in vivo analyses show that CGRP treatment inhibited Ang II‐induced VSMC proliferation and hypertrophy, accompanied by a reduction in ROS generation. Collectively, these results demonstrate that CGRP exhibits its antioxidative effect by blocking the Src/STAT3 signalling pathway that is associated with Ang II‐induced VSMC hypertrophy and hyperplasia.

3 April 2025 in Journal of Autoimmunity
Verified
Journal Article
Closed access
YYYuanyuan Yang
Yuanyuan Yang
WLWencong Liu
Wencong Liu
ZZZechang Zhang
Zechang Zhang
YZYujia Zhang
Yujia Zhang
XWXuebin Wang
Xuebin Wang
WLWenxuan Liu
Wenxuan Liu

5 December 2023 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
TLTeng Liu
Teng Liu
YJYu-Qing Jin
Yu-Qing Jin
QWQi Wang
Qi Wang
CJCong-Hui Jia
Cong-Hui Jia
WRWei-Yan Ren
Wei-Yan Ren
HLHongmin Luo
Hongmin Luo
Objective: Diabetic nephropathy (DN) is a serious chronic complication of diabetes mellitus (DM). Endoplasmic reticulum (ER) stress is an important factor in the regulation of pathological processes in DN, and excessive ER stress can lead to apoptosis. Although the IL-33/ST2 axis is known to be involved in diabetic kidney disease or related nephropathy, its role and molecular mechanisms remain poorly understood in terms of DN. The purpose of this study was to investigate the effects of IL-33/ST2 signaling on DN and to characterize the roles that ER stress and apoptosis play in DN. Methods: To investigate this study, mice were randomly assigned into DN (induced by 0.1% STZ) and Control groups. Biochemical indices (FBG, BUN, UPR, UCE) were measured in serum and urine samples to reflect blood glucose and kidney damage. Quantitative real-time PCR, western blot, and immunofluorescence were used to assess gene and protein expression of the IL-33/ST2 axis and ER stress relative signaling molecule. Apoptosis was analyzed by flow cytometry. Results: IL-33 levels are significantly increased in the kidneys of patients and mice with DN. Double immunofluorescence staining showed that IL-33 colocalized with CD31-positive endothelial cells. Treatment with IL-33 attenuated kidney injury in Streptozotocin (STZ)-treated mice. In vitro, we showed that IL-33 attenuated ER stress and apoptosis in glomerular endothelial cells. However, sST2 treatment significantly reversed these effects of IL-33. Conclusion: Together, these data suggest that IL-33/ST2 signaling mitigates STZ-induced renal damage, partly at least, by suppressing ER stress and apoptosis. Therefore, IL-33 may be an effective therapeutic target in DN.

1 January 2020 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
HLHong-Min Luo
Hong-Min Luo
XWXia Wu
Xia Wu
WLWen-Xuan Liu
Wen-Xuan Liu
LWLu-Yao Wang
Lu-Yao Wang
HSHong-Yu Sun
Hong-Yu Sun
LYlei yang
lei yang